Ceftazidime-Avibactam Treatment for Severe Post-Neurosurgical Meningitis and Abscess Caused by Extended-Spectrum β-Lactamase Escherichia coli in a Pediatric Patient: A Case Report

References

• Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis. 2009;9(4):245–255. doi:10.1016/S1473-3099(09)70055-6
   PubMed Web of Science ®Google Scholar
• Li Z, Wu X, Yu J, et al. Empirical combination antibiotic therapy improves the outcome of nosocomial meningitis or ventriculitis in neuro-critical care unit Patients. Surg Infect (Larchmt). 2016;17(4):465–472. doi:10.1089/sur.2015.060
   PubMed Web of Science ®Google Scholar
• Reichert MC, Medeiros EA, Ferraz FA. Hospital-acquired meningitis in patients undergoing craniotomy: incidence, evolution, and risk factors. Am J Infect Control. 2002;30(3):158–164. doi:10.1067/mic.2002.119925
   PubMed Web of Science ®Google Scholar
• Holyk A, Belden V, Lee JJ, et al. Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report. J Antimicrob Chemother. 2018;73:254–256.
   PubMed Web of Science ®Google Scholar
• Pektezel MY, Isikay I, Gocmen R, et al. Carbapenem-resistant Klebsiella pneumoniae meningitis and abscess treated with ceftazidime-avibactam. Enferm Infecc Microbiol Clin. 2022;40:332–333.
   Web of Science ®Google Scholar
• Zhou Q, Wang H, Zhan TX, et al. Successful treatment of ventriculitis caused by MDR/XDR Gram-negative Bacillus using ceftazidime/avibactam: case series and literature review. Infect Drug Resist. 2021;14:1691–1701. doi:10.2147/IDR.S306222
   PubMed Web of Science ®Google Scholar
• Yasmin M, Hanrahan J, Marshall S, et al. Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae central nervous system infection with ceftazidime/avibactam. Open Forum Infect Dis. 2020;7(9):ofaa349. doi:10.1093/ofid/ofaa349
   PubMed Web of Science ®Google Scholar
• Gatti M, Virgili G, Cojutti PG, et al. Real-time optimization of pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant Gram negatives with ceftazidime-avibactam-based regimens: a report of two cases. Microorganisms. 2022;10(1):154. doi:10.3390/microorganisms10010154
   PubMed Web of Science ®Google Scholar
• Gofman N, To K, Whitman M, et al. Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin. Am J Health Syst Pharm. 2018;75(13):953–957. doi:10.2146/ajhp170632
   PubMed Web of Science ®Google Scholar
• Daccò V, Claut L, Piconi S, et al. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis. Transpl Infect Dis. 2019;21:e13082.
   PubMed Web of Science ®Google Scholar
• Xipell M, Bodro M, Marco F, et al. Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents. 2017;49:266–268.
   PubMed Web of Science ®Google Scholar
• Almangour TA, Alsubaie S, Ghonem L, et al. Ceftazidime-avibactam for the treatment of multidrug-resistant Pseudomonas aeruginosa central nervous system infection in pediatric patient: a case report. Pediatr Infect Dis J. 2022;41:436–438.
   PubMed Web of Science ®Google Scholar
• Wang QH, Zheng Y, Liu LL, et al. Simultaneous determination of ceftazidime and avibactam in human plasma and cerebrospinal fluid by high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS). Analatical Letters. 2023;56(5):816–831. doi:10.1080/00032719.2022.2105859
   Web of Science ®Google Scholar
• Kaye KS, Bhowmick T, Metallidis S, et al. Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I randomized clinical trial. JAMA. 2018;319(8):788–799. doi:10.1001/jama.2018.0438
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-associated Ventriculitis and Meningitis. Clin Infect Dis. 2017;64(6):e34–e65. doi:10.1093/cid/ciw861
   PubMed Web of Science ®Google Scholar
• Veillette JJ, Truong J, Forland SC. Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment. Pharmacotherapy. 2016;36(11):e172–e177. doi:10.1002/phar.1840
   PubMed Web of Science ®Google Scholar
• Crass RL, Pai MP. Pharmacokinetics and pharmacodynamics of β-lactamase inhibitors. Pharmacotherapy. 2019;39(2):182–195. doi:10.1002/phar.2210
   PubMed Web of Science ®Google Scholar
• Berkhout J, Melchers MJ, van Mil AC, et al. Pharmacodynamics of ceftazidime and avibactam in neutropenic mice with thigh or lung infection. Antimicrob Agents Chemother. 2016;60(1):368–375. doi:10.1128/AAC.01269-15
   PubMed Web of Science ®Google Scholar
• Lutsar I, McCracken, Jr. GH, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis. 1998;27(5):1117–1127. doi:10.1086/515003
   PubMed Web of Science ®Google Scholar
• Nau R, Sörgel F, Prange HW. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet. 1998;35(3):223–246. doi:10.2165/00003088-199835030-00005
   PubMed Web of Science ®Google Scholar
• Katip W, Yoodee J, Uitrakul S, et al. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae. Sci Rep;2021 11 1 . 18. doi:10.1038/s41598-020-78098-4
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Galani L, Baziaka F, et al. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013;41 6 :499–508.
   PubMed Web of Science ®Google Scholar
• Tanglm CST. Klebsiella pneumoniae meningitis: prognostic factors. Scand J Infect Dis. 1994;26 1 :95–102..
   PubMedGoogle Scholar